Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases

Stopped After 1 year only 2 subjects enrolled and treated thus no meaningful efficacy analyses could be performed.

Conditions

• Colorectal Neoplasms
• Liver Neoplasms

Interventions

• DRUG: Combination therapy of irinotecan with 5-FU, leucovorin plus bevacizumab in the neoadjuvant setting.

Sponsor

Pfizer